E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke

Toxicology Mechanisms and Methods

Volumn 26, Issue 6, 2016, Pages 465-476

  Taylor, Mark ^a   Carr, Tony ^a   Oke, Oluwatobiloba ^a   Jaunky, Tomasz ^a   Breheny, Damien ^a   Lowe, Frazer ^a   Gaça, Marianna ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

Bronchial epithelial; Cigarette smoke; e cigarettes; in vitro; Oxidative stress

Indexed keywords

2 BUTANONE; ACETALDEHYDE; ACETONE; ACROLEIN; BUTYRALDEHYDE; CARBONYL DERIVATIVE; CASPASE 3; CASPASE 7; CIGARETTE SMOKE; CROTONALDEHYDE; FORMALDEHYDE; GLUTATHIONE; NICOTINE; PROPIONALDEHYDE; TOBACCO SMOKE; TRANSCRIPTION FACTOR NRF2; AEROSOL; SMOKE;

ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CELL DEATH; CELL POPULATION; CELL VIABILITY; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ELECTRONIC CIGARETTE; ENZYME ACTIVITY; HBEC CELL LINE (BRONCHIAL EPITHELIUM); HUMAN; HUMAN CELL; IN VITRO STUDY; NCI-H292 CELL LINE; OPTICAL DENSITY; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; ADVERSE EFFECTS; AEROSOL; BRONCHUS; CELL CULTURE TECHNIQUE; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; METABOLISM; SMOKE; TOBACCO; TOXICITY;

AEROSOLS; BRONCHI; CELL CULTURE TECHNIQUES; CELL LINE; ELECTRONIC CIGARETTES; EPITHELIAL CELLS; HUMANS; NICOTINE; OXIDATIVE STRESS; SMOKE; TOBACCO;

EID: 85006826895     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376516.2016.1222473     Document Type: Article

References (72)

1. Alexandrov K, Rojas M, Rolando C. (2006). DNA damage by benzo(a)pyr-ene in human cells is increased by cigarette smoke and decreased by a filter containing rosemary extract, which lowers rree radicals. Cancer Res 66:11938-45.
2. American Council on Science and Health (ACSH). (2015). E-cigarette study gets big headlines, but what does it mean? [Internet]. New York (NY): ACSH. Available from: http://acsh.org/news/2015/01/22/poorly-done-e-cig-vapor-study-gets-big-headlines-means-nothing/ [last accessed 8 Jul 2016].
3. Azzopardi D, Patel K, Jaunky T, et al. (2016). Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Toxicol Meth Mech; in press.
4. Bahla V, Lin S, Xu N, et al. (2012). Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 34:529-53.
5. Barnes P, Shapiro SD, Pauwels RA. (2003). Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22:672-88.
6. Bekki K, Uchiyama S, Ohta K, et al. (2014). Carbonyl compounds generated from electronic cigarettes. Int J Environ Res Public Health 11:11192-200.
7. Bernhard D, Wang XL. (2007). Smoking, oxidative stress and cardiovascular diseases-do anti-oxidative therapies fail? Curr Med Chem 14:1703-12.
8. Biener L, Hargraves JL. (2014). A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res 17:127-33.
9. Burstyn I. (2014). Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health 14:18.
10. Callahan-Lyon P. (2014). Electonic cigarettes: human health effects. Tob Cont 23:11, 36-40.
11. Caponnetto P, Campagna D, Cibella F, et al. (2013). EffiCiency and safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 8:e66317.
12. Chen B, Liu Y, Chen Y, et al. (2015). The role of Nrf2 in oxidative stress-induced endothelial injuries. J Endocrinol 225:R83-99.
13. Cheng T. (2014). Chemical evaluation of e-cigarettes. Tob Cont 23:11, 11-17.
14. Ciencewicki J, Trivedi S, Kleeberger SR. (2008). Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol 122:456-70.
15. Cosgrove JP, Borish ET, Church DF, et al. (1985). The metal mediated formation of hydroxyl radical by aqueous extracts of cigarette tar. Biochem Biophys Res Commun 132:390-6.
16. Culpitt S, Rogers DF, Fenwick PS, et al. (2003). Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 58:942-6.
17. Demedts IK, Demoor T, Bracke KR, et al. (2006). Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 7:53.
18. Djordjevic VB. (2004). Free radicals in cell biology. Int Rev Cytol 237:57-89.
19. Espinosa-Diez C, Miguel V, Mennerich D, et al. (2015). Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol 6:183-97.
20. Facchinetti F, Amadei F, Geppetti P, et al. (2007). Alpha,beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am J Respir Cell Mol Biol 37:617-23.
21. Farsalinos KE, Romagna G, Allifranchini E, et al. (2013). Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapor extract on cultured myocardial cells. Int J Environ Res Public Health 10:5146-62.
22. Farsalinos KE, Romagna G, Tsiapras D, et al. (2014). Characteristics, perceived side-effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health 11:4356-73.
23. Farsalinos KE, Voudris V, Poulas K. (2015). E-cigarettes generate high levels of aldehydes only in 'dry puff' conditions. Addiction 110:1352-6.
24. Farsalinos K, Cibella F, Caponnetto P, et al. (2016). Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Intern Emerg Med 11:85-94.
25. Faux S, Tai T, Thorne D, et al. (2009). The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers 14:90-6.
26. Goel R, Durand E, Trushin N, et al. (2015). Highly reactive free radicals in electronic cigarette aerosols. Chem Res Toxicol 28:1675-57.
27. Goniewicz ML, Knysak J, Gawron M, et al. (2014). Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Cont 23:133-9.
28. Gould NS, Min E, Gauthier S, et al. (2011). Lung glutathione adaptive responses to cigarette smoke exposure. Respir Res 12:133.
29. Hajek P, Etter JF, Benowitz N, et al. (2014). Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 109:1801-10.
30. Health Canada. (1999). Official method T-116. "Determination of 1,3-butadiene, isoprene, acrylonitrile, benzene and toluene in mainstream tobacco smoke”. Ottawa: Health Canada.
31. Horinouchi T, Higashi T, Mazaki Y, et al. (2016). Carbonyl compounds in the gas phase of cigarette mainstream smoke and their pharmacological properties. Biol Pharm Bull 39:909-14.
32. Iksandar AR, Gonzalez-Suarez I, Majeed S, et al. (2016). A framework for in vitro systems toxicology assessment of e-liquids. Toxicol Mech Meth 26:1-24.
33. International Organization for Standardization. (2015). ISO 3402:1999. Tobacco and tobacco products - atmosphere for conditioning and testing. Geneva: International Organization for Standardization.
34. Invernizzi G, Ruprecht A, Mazza R, et al. (2004). Particulate matter from tobacco versus diesel car exhaust: an educational perspective. Tob Cont 13:219-21.
35. Jensen RP, Luo W, Pankow JF, et al. (2015). Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 372:392-4.
36. Kannan K, Jain SK. (2000). Oxidative stress and apoptosis. Pathophysiology 7:153-63.
37. Kilford J, Thorne D, Payne R, et al. (2014). A method for assessment of the genotoxicity of mainstream cigarette smoke by use of the bacterial reverse-mutation assay and an aerosol-based exposure system. Mutat Res Genet Toxicol Environ Mutagen 769:20-8.
38. Kluchova Z, Petrasova D, Joppa P, et al. (2007). The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res Acad Sci Bohemoslov 56:51-6.
39. Kosmider L, Sobczak A, Fik M, et al. (2014). Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res 16:1319-26.
40. Lerner CA, Sundar IK, Yao H, et al. (2015). Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 10:e0116732.
41. Li N, Kim S, Wang M, et al. (2002). Use of a stratified oxidative stress model to study the biological effects of ambient concentrated and diesel exhaust particulate matter. Inhal Toxicol 14:459-86.
42. Lowe F, Fearon IM, Camacho O, et al. (2015). A framework for the assessment of reduced-risk tobacco and nicotine products. 69th Tobacco Science Research Conference (TSRC), 20-23 September 2015, Naples, FL.
43. Margham J, McAdam K, Forster M, et al. (2016). Chemical composition of an e-cigarette aerosol: a quantitative comparison with cigarette smoke. Chem Res Toxicol. doi: 10.1021/acs.chemrestox.6b00188.
44. Maunders H, Patwardhan S, Phillips J, et al. (2007). Human bronchial epithelial cell transcriptome: gene expression changes following acute exposure to whole cigarette smoke in vitro. Am J Physiol Lung Cell Mol Physiol 292:L1248-56.
45. Misra M, Leverette RD, Cooper BT, et al. (2014). Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. Int J Environ Res Public Health 11:11325-47.
46. Muller T, Haussmann HJ, Schepers G. (1997). Evidence for peroxynitrite as an oxidative stress-inducing compound of aqueous cigarette smoke fractions. Carcinogenesis 18:295-301.
47. Muller T, Gebel S. (1998). The cellular stress response induced by aqueous extracts of cigarette smoke is critically dependent on the intracellular glutathione concentration. Carcinogenesis 19:797-801.
48. Neilson L, Mankus C, Thorne D, et al. (2015). Development of an in vitro cytotoxicity model for aerosol exposure using 3D reconstructed human airway tissue: application for assessment of e-cigarette aerosol. Toxicol in Vitro 29:1952-62.
49. Noya Y, Seki K, Asano H, et al. (2013). Identification of stable cytotoxic factors in the gas phase extract of cigarette smoke and pharmacological characterization of their cytotoxicity. Toxicology 314:1-10.
50. Pellegrino RM, Tinghino B, Mangiaracina G, et al. (2012). Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig 24:279-88.
51. Pryor WA. (1997). Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Persp 105:875-82.
52. Public Health England. (2015). E-cigarettes: an evidence update. London: Public Health England.
53. Reuter S, Gupta SC, Chaturvedi MM, et al. (2010). Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49:1603-16.
54. Roemer E, Shramke H, Weiler H, et al. (2012). Mainstream smoke chemistry and in vitro and in vivo toxicity of the reference cigarettes 3R4F and 2R4F. Beiträge zur Tabakforschung International/Contrib Tob Res 25:316-35.
55. Romagna G, Allifranchini E, Bocchietto E, et al. (2013). Cytotoxicity evaluation of e-cigarette vapor extract on cultured mammalian fibroblasts (clearstream-life): comparison with tobacco cigarette smoke extract. Inhal Toxicol 25:354-61.
56. Royal College of Physicians. (2016). Nicotine without smoke: tobacco harm reduction. London: RCP.
57. Sato E, Koyama S, Takamizawa A, et al. (1999). Smoke extract stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activities. Am J Physiol 277:L1149-57.
58. Scheffler S, Dieken H, Krischenowski O, et al. (2015a). Cytotoxic evaluation of e-liquid aerosol using different lung-derived cell models. Int J Environ Res Public Health 12:12466-74.
59. Scheffler S, Dieken H, Krischenowski O, et al. (2015b). Evaluation of e-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary Human bronchial epithelial cells. Int J Environ Res Public Health 12:3915-25.
60. Schlage WK, Iskandar AR, Kostadinova R, et al. (2014). In vitro systems toxicology approach to investigate the effects of repeated cigarette smoke exposure on human buccal and gingival organotypic epithelial tissue cultures. Toxicol Mech Meth 24:470-87.
61. Sethi JM, Rochester CL. (2000). Smoking and chronic obstructive pulmonary disease. Clin Chest Med 21:67-86. viii.
62. Tavilani H, Nadi E, Karimi J, et al. (2012). Oxidative stress in COPD patients, smokers, and nonsmokers. Respir Care 57:2090-4.
63. Taylor M, Vella L, Carr T. (2014). Assessment of an in vitro model of lung epithelial cell stress responses. Free Rad Biol Med 75:S51.
64. Thorne D, Adamson J. (2013). A review of in vitro cigarette smoke exposure systems. Exp Toxicol Pathol 65:1183-93.
65. Thorne D, et al. (2016). The mutagenic assessment of electronic-ciga-rettes and tobacco smoke using the Ames assay in strains TA98 and TA100. Mutat Res, in press.
66. van der Toorn M, Smit-de Vries MP, Slebos DJ, et al. (2007). Cigarette smoke irreversibly modifies glutathione in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 293:L1156-62.
67. Vayssier M, Banzet N, Francois D, et al. (1998). Tobacco smoke induces both apoptosis and necrosis in mammalian cells: differential effects of HSP70. Am J Physiol 275:L771-9.
68. Volpi G, Facchinetti F, Moretto N, et al. (2011). Cigarette smoke and a,b-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts. Br J Pharmacol 163:649-61.
69. Walters MJ, Paul-Clark MJ, McMaster SK, et al. (2005). Cigarette smoke activates human monocytes by an oxidant-AP-1 signaling pathway: implications for steroid resistance. Mol Pharmacol 68:1343-53.
70. Wirtz HR, Schmidt M. (1996). Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture. Eur Respir J 9:24-32.
71. Wiseman H, Halliwell B. (1996). Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313:17-29.
72. Zitka O, Skalickova S, Gumulec J, et al. (2012). Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients. Oncol Lett 4:1247-53.